Conjunctivitis

Conjunctivitis , most commonly due to an allergic reaction or an infection . Blepharoconjunctivitis is the combination of conjunctivitis with blepharitis .Keratoconjunctivitis is the combination of conjunctivitis and keratitis .Episcleritis is an inflammatory condition that produces a similar appearance to conjunctivitis, but without discharge or tearing. (From the Wikpedia article Conjunctivitis.)

Download PDF containing detailed information.

Recent Publications on Conjunctivitis:
Vernal keratoconjunctivitis-A rare but serious comorbidity of allergic rhinitis and eustachian tube dysfunction. OBJECTIVE: To determine the prevalence of symptoms and signs of allergic...	11th November, 2009	Department of Otolaryngology Head and Neck Surgery, Selcuk University,	Int J Pediatr Otorhinolaryngol. 2009 Nov 7. DOI Direct Link
Ocular pharmacokinetics of AzaSite Xtra-2% azithromycin formulated in a DuraSite delivery system. PURPOSE: The pharmacokinetics of a 2% ocular solution of azithromycin in...	11th November, 2009	Department of Preclinical Research, InSite Vision, Alameda, California,	Curr Eye Res. 2009 Jun;34(6):485-91.
Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction. PURPOSE: To understand the mechanisms of action of cyclosporin A eye drops...	11th November, 2009	Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16	Curr Eye Res. 2009 Jun;34(6):426-37.
[Ophthalmology] Allergic conjunctival diseases caused by immediate hypersensitivity are...	11th November, 2009	Department of Ophthalmology, Tokyo Women's Medical University, School of	Nippon Rinsho. 2009 Nov;67(11):2157-61.
[New approach and recommendation in JAGL2007 (Japanese guideline for the diagnosis and treatment of allergic diseases 2007)] Recently prevalence of allergic diseases has become increasing all over...	11th November, 2009	Fukuoka National Hospital.	Nippon Rinsho. 2009 Nov;67(11):2039-42.
→View more research publications.

Press Releases About Conjunctivitis:
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)	9th November, 2009	ISTA Pharmaceuticals, Inc.	MIAMI, Nov. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting	21st October, 2009	ISTA Pharmaceuticals, Inc.	ANAHEIM, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate
MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes	11th August, 2009	MinuteClinic	ATLANTA, Aug. 11 /PRNewswire/ -- MinuteClinic, the pioneer and largest provider of retail-based health care in the United States, is now offering a first-of-its kind rapid conjunctivitis (pink-eye)
Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')	29th May, 2009	Bausch & Lomb	- Besivance Adds to Bausch & Lomb's Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) - MADISON, N.J., May 29
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting	7th May, 2009	ISTA Pharmaceuticals, Inc.	FT. LAUDERDALE, Fla., May 7 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today presented results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution)

BioNews Results for Conjunctivitis:
NovaBay Pharmaceuticals Reports Third Quarter Financials and Provides Update on Pipeline of Anti-Infective Com	Pharmacy Choice:  Nov 14 2009 12:58AM Matching: conjunctivitis
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College o	Entrepreneur.com:  Nov 11 2009 11:11AM Matching: conjunctivitis
ISTA Pharmaceuticals Highlights Bepreve Clinical Data at the 2009 Annual Meeting of the American College of Al	Pharma Live:  Nov 10 2009 9:38PM Matching: conjunctivitis
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data At The 2009 Annual Meeting Of The American College O	Medical News Today:  Nov 10 2009 9:27AM Matching: conjunctivitis
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy,	NewsBlaze:  Nov 9 2009 12:42PM Matching: conjunctivitis
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Conjunctivitis Clinical Trials:
A Study to Determine if BOL-303224 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

Conjunctivitis Patents:
US Patent No.	Title
7595151	Methods and compositions for diagnosis and treatment of influenza
7598392	2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof
7601531	Chlamydia pneumoniae polynucleotides and uses thereof
7601712	Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
7601713	Kinase inhibitors and their uses
→View more patents.

Companies working in the area of Conjunctivitis from Bioportfolio's Biocorporate database :
Company Name
Evolutec Group plc Evolutec discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. Evolutec has progressed its lead therapeutic molecule, rEV131, a novel histamine... www.evolutec.co.uk/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Conjunctivitis scientists - we have details of around 1108 individuals working on Conjunctivitis .